The foundation of our solution platform for specialty benefits management is our clinical appropriateness guidelines.
AIM Clinical Appropriateness Guidelines for Radiation Oncology are developed through a rigorous process integrating evidence-based literature with expert physician review. Included below are guidelines for radiation therapy and proton beam therapy.
Effective March 9, 2019, the enhanced AIM Specialty Health General Clinical Guideline will replace the Administrative Guidelines which previously applied to AIM Clinical Appropriateness Guidelines for Radiology. The new General Clinical Guideline standardizes language related to clinical appropriateness, simultaneous ordering of multiple diagnostic or therapeutic interventions, and repeat diagnostic or therapeutic interventions, making this information applicable to all AIM Clinical Appropriateness Guidelines—Radiology, Cardiology, Sleep Medicine, Radiation Oncology, and Musculoskeletal. There are no changes to specific clinical criteria.
AIM Clinical Appropriateness Guidelines for Radiation Oncology
The treatments addressed in the AIM Clinical Appropriateness Guidelines for Radiation Oncology include brachytherapy, intensity-modulated radiation therapy, stereotactic body radiation therapy, and stereotactic radiosurgery.
OPEN THE GUIDELINES FOR RADIATION ONCOLOGY
AIM Clinical Appropriateness Guidelines for Proton Beam Treatment
The treatment addressed in the AIM Clinical Appropriateness Guidelines for Proton Beam Treatment is proton beam therapy, also known as proton radiation therapy or proton radiotherapy.
OPEN THE GUIDELINES FOR Proton Beam Treatment
Trouble viewing the guidelines?
To open our guidelines, your computer needs Adobe Reader, a free and trusted software that allows you to view PDFs.
GET ADOBE READER